He doesn’t think it’s a critical market sensitive milestone, but as a retail shareholder with a simple mind; it upgrades us to a new category within the industry and hopefully we’ll get some renewed recognition of dosing our molecules in humans instead of in the lab/animals. This recognition will hopefully be two fold - sharemarkets and industry.
But I will take his advice hint/advice to back off from sweating the small stuff and let the team get on with the excellent science and potential of the platform - which is the reason why we are all still here
Rohan said it has been the best 6 months of scientific breakthroughs they had - will check back with you all at the AGM!
- Forums
- ASX - By Stock
- PYC
- Ann: Phelan-McDermid Syndrome & CNS platform presentation
Ann: Phelan-McDermid Syndrome & CNS platform presentation, page-30
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $536.6M |
Open | High | Low | Value | Volume |
10.5¢ | 12.0¢ | 10.5¢ | $897.8K | 7.975M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 111298 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 923061 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 111298 | 0.110 |
8 | 1041786 | 0.105 |
33 | 2159692 | 0.100 |
2 | 21386 | 0.099 |
4 | 75300 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 923061 | 10 |
0.125 | 180772 | 4 |
0.130 | 388324 | 5 |
0.135 | 302356 | 3 |
0.140 | 753642 | 3 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online